Recombinant viruses encoding the human melanoma-associated antigen
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 16, 1993
Issued Date -
N/A
app pub date -
Jan 27, 1987
filing date -
Feb 7, 1986
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Peptides or proteins related to a melanoma associated antigen are described. These are produced in large quantities via recombinant DNA techniques and/or by chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which can induce an immune response that selectively destroys melanoma cells in a vaccinated individual. Where the peptides or proteins are expressed by a recombinant virus, inactivated or live virus vaccine formulations may be prepared.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully